Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 May;11(5):419-26.
doi: 10.1038/ni.1858. Epub 2010 Apr 4.

HIV-1 exploits innate signaling by TLR8 and DC-SIGN for productive infection of dendritic cells

Affiliations

HIV-1 exploits innate signaling by TLR8 and DC-SIGN for productive infection of dendritic cells

Sonja I Gringhuis et al. Nat Immunol. 2010 May.

Abstract

Pattern-recognition receptors (PRRs) elicit antiviral immune responses to human immunodeficiency virus type 1 (HIV-1). Here we show that HIV-1 required signaling by the PRRs Toll-like receptor 8 (TLR8) and DC-SIGN for replication in dendritic cells (DCs). HIV-1 activated the transcription factor NF-kappaB through TLR8 to initiate the transcription of integrated provirus by RNA polymerase II (RNAPII). However, DC-SIGN signaling was required for the generation of full-length viral transcripts. Binding of the HIV-1 envelope glycoprotein gp120 to DC-SIGN induced kinase Raf-1-dependent phosphorylation of the NF-kappaB subunit p65 at Ser276, which recruited the transcription-elongation factor pTEF-b to nascent transcripts. Transcription elongation and generation of full-length viral transcripts was dependent on pTEF-b-mediated phosphorylation of RNAPII at Ser2. Inhibition of either pathway abrogated replication and prevented HIV-1 transmission. Thus, HIV-1 subverts crucial components of the immune system for replication that might be targeted to prevent infection and dissemination.

PubMed Disclaimer

Comment in

References

    1. Proc Natl Acad Sci U S A. 1997 Sep 2;94(18):9825-30 - PubMed
    1. Immunity. 2002 Jan;16(1):135-44 - PubMed
    1. Nature. 1987 Dec 3-9;330(6147):489-93 - PubMed
    1. Immunity. 2007 Oct;27(4):549-59 - PubMed
    1. J Exp Med. 2002 May 20;195(10):1359-70 - PubMed

Publication types

MeSH terms

Substances